Europe Polypeptide Drug Market Research Report Forecast 2017-2022

April 2017 | 134 pages | ID: E238996E540EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The Europe Polypeptide Drug Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Polypeptide Drug industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Polypeptide Drug market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Europe Polypeptide Drug Market Analysis by Countries:

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

The Major players reported in the market include:

Novartis
Merck Serono
Ferring Pharmaceuticals
Ipsen PHarma Biotech
Lilly
Asahi Kasei
AstraZeneca
SciClone Pharmaceuticals
Takeda

Europe Polypeptide Drug Market Analysis by Product:

• Type 1
• Type 2
• Type 3

Europe Polypeptide Drug Market Analysis by Application:

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

1 POLYPEPTIDE DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Polypeptide Drug
1.2 Classification of Polypeptide Drug
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Polypeptide Drug
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Polypeptide Drug Market States Status and Prospect (2012-2022) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Polypeptide Drug (2012-2022)
  1.5.1 Europe Polypeptide Drug Sales and Growth Rate (2012-2022)
  1.5.2 Europe Polypeptide Drug Revenue and Growth Rate (2012-2022)

2 EUROPE ECONOMIC IMPACT ON POLYPEPTIDE DRUG INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 POLYPEPTIDE DRUG MANUFACTURING COST ANALYSIS

3.1 Polypeptide Drug Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Polypeptide Drug

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Polypeptide Drug Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Polypeptide Drug Major Manufacturers in 2016
4.4 Downstream Buyers

5 EUROPE POLYPEPTIDE DRUG MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Polypeptide Drug Market Competition by Manufacturers
  5.1.1 Europe Polypeptide Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Polypeptide Drug Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Polypeptide Drug (Volume and Value) by Type
  5.2.1 Europe Polypeptide Drug Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Polypeptide Drug Revenue and Market Share by Type (2012-2017)
5.3 Europe Polypeptide Drug (Volume and Value) by Countries
  5.3.1 Europe Polypeptide Drug Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Polypeptide Drug Revenue and Market Share by Countries (2012-2017)
5.4 Europe Polypeptide Drug (Volume) by Application

6 GERMANY POLYPEPTIDE DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Polypeptide Drug Sales and Value (2012-2017)
  6.1.1 Germany Polypeptide Drug Sales and Growth Rate (2012-2017)
  6.1.2 Germany Polypeptide Drug Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Polypeptide Drug Sales Price Trend (2012-2017)
6.2 Germany Polypeptide Drug Sales and Market Share by Manufacturers
6.3 Germany Polypeptide Drug Sales and Market Share by Type
6.4 Germany Polypeptide Drug Sales and Market Share by Application

7 FRANCE POLYPEPTIDE DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 France Polypeptide Drug Sales and Value (2012-2017)
  7.1.1 France Polypeptide Drug Sales and Growth Rate (2012-2017)
  7.1.2 France Polypeptide Drug Revenue and Growth Rate (2012-2017)
  7.1.3 France Polypeptide Drug Sales Price Trend (2012-2017)
7.2 France Polypeptide Drug Sales and Market Share by Manufacturers
7.3 France Polypeptide Drug Sales and Market Share by Type
7.4 France Polypeptide Drug Sales and Market Share by Application

8 UK POLYPEPTIDE DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 UK Polypeptide Drug Sales and Value (2012-2017)
  8.1.1 UK Polypeptide Drug Sales and Growth Rate (2012-2017)
  8.1.2 UK Polypeptide Drug Revenue and Growth Rate (2012-2017)
  8.1.3 UK Polypeptide Drug Sales Price Trend (2012-2017)
8.2 UK Polypeptide Drug Sales and Market Share by Manufacturers
8.3 UK Polypeptide Drug Sales and Market Share by Type
8.4 UK Polypeptide Drug Sales and Market Share by Application

9 RUSSIA POLYPEPTIDE DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Polypeptide Drug Sales and Value (2012-2017)
  9.1.1 Russia Polypeptide Drug Sales and Growth Rate (2012-2017)
  9.1.2 Russia Polypeptide Drug Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Polypeptide Drug Sales Price Trend (2012-2017)
9.2 Russia Polypeptide Drug Sales and Market Share by Manufacturers
9.3 Russia Polypeptide Drug Sales and Market Share by Type
9.4 Russia Polypeptide Drug Sales and Market Share by Application

10 ITALY POLYPEPTIDE DRUG (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Polypeptide Drug Sales and Value (2012-2017)
  10.1.1 Italy Polypeptide Drug Sales and Growth Rate (2012-2017)
  10.1.2 Italy Polypeptide Drug Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Polypeptide Drug Sales Price Trend (2012-2017)
10.2 Italy Polypeptide Drug Sales and Market Share by Manufacturers
10.3 Italy Polypeptide Drug Sales and Market Share by Type
10.4 Italy Polypeptide Drug Sales and Market Share by Application

11 SPAIN POLYPEPTIDE DRUG (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Polypeptide Drug Sales and Value (2012-2017)
  11.1.1 Spain Polypeptide Drug Sales and Growth Rate (2012-2017)
  11.1.2 Spain Polypeptide Drug Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Polypeptide Drug Sales Price Trend (2012-2017)
11.2 Spain Polypeptide Drug Sales and Market Share by Manufacturers
11.3 Spain Polypeptide Drug Sales and Market Share by Type
11.4 Spain Polypeptide Drug Sales and Market Share by Application

12 BENELUX POLYPEPTIDE DRUG (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Polypeptide Drug Sales and Value (2012-2017)
  12.1.1 Benelux Polypeptide Drug Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Polypeptide Drug Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Polypeptide Drug Sales Price Trend (2012-2017)
12.2 Benelux Polypeptide Drug Sales and Market Share by Manufacturers
12.3 Benelux Polypeptide Drug Sales and Market Share by Type
12.4 Benelux Polypeptide Drug Sales and Market Share by Application

13 EUROPE POLYPEPTIDE DRUG MANUFACTURERS ANALYSIS

13.1 Novartis
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 Merck Serono
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Ferring Pharmaceuticals
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 Ipsen PHarma Biotech
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 Lilly
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 Asahi Kasei
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 AstraZeneca
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 SciClone Pharmaceuticals
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 Takeda
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE POLYPEPTIDE DRUG MARKET FORECAST (2017-2022)

15.1 Germany Market Forecast (2017-2022)
15.2 France Market Forecast (2017-2022)
15.3 UK Market Forecast (2017-2022)
15.4 Russia Market Forecast (2017-2022)
15.5 Italy Market Forecast (2017-2022)
15.6 Spain Market Forecast (2017-2022)
15.7 Benelux Market Forecast (2017-2022)
15.8 Europe Polypeptide Drug Market Forecast by Type (2017-2022)
15.9 Europe Polypeptide Drug Market Forecast by Application (2017-2022)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Polypeptide Drug
Table Classification of Polypeptide Drug
Figure Europe Sales Market Share of Polypeptide Drug by Type in 2016
Table Application of Polypeptide Drug
Figure Europe Sales Market Share of Polypeptide Drug by Application in 2016
Figure Germany Polypeptide Drug Revenue and Growth Rate (2012-2022)
Figure France Polypeptide Drug Revenue and Growth Rate (2012-2022)
Figure UK Polypeptide Drug Revenue and Growth Rate (2012-2022)
Figure Russia Polypeptide Drug Revenue and Growth Rate (2012-2022)
Figure Italy Polypeptide Drug Revenue and Growth Rate (2012-2022)
Figure Spain Polypeptide Drug Revenue and Growth Rate (2012-2022)
Figure Benelux Polypeptide Drug Revenue and Growth Rate (2012-2022)
Figure Europe Polypeptide Drug Sales and Growth Rate (2012-2022)
Figure Europe Polypeptide Drug Revenue and Growth Rate (2012-2022)
Table Europe Polypeptide Drug Sales of Key Manufacturers (2015 and 2016)
Table Europe Polypeptide Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Polypeptide Drug Sales Share by Manufacturers
Figure 2016 Polypeptide Drug Sales Share by Manufacturers
Table Europe Polypeptide Drug Revenue by Manufacturers (2015 and 2016)
Table Europe Polypeptide Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Polypeptide Drug Revenue Share by Manufacturers
Table 2016 Europe Polypeptide Drug Revenue Share by Manufacturers
Table Europe Polypeptide Drug Sales and Market Share by Type (2012-2017)
Table Europe Polypeptide Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Polypeptide Drug by Type (2012-2017)
Figure Europe Polypeptide Drug Sales Growth Rate by Type (2012-2017)
Table Europe Polypeptide Drug Revenue and Market Share by Type (2012-2017)
Table Europe Polypeptide Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Polypeptide Drug by Type (2012-2017)
Figure Europe Polypeptide Drug Revenue Growth Rate by Type (2012-2017)
Table Europe Polypeptide Drug Sales and Market Share by Countries (2012-2017)
Table Europe Polypeptide Drug Sales Share by Countries (2012-2017)
Figure Sales Market Share of Polypeptide Drug by Countries (2012-2017)
Table Europe Polypeptide Drug Revenue and Market Share by Countries (2012-2017)
Table Europe Polypeptide Drug Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Polypeptide Drug by Countries (2012-2017)
Table Europe Polypeptide Drug Sales and Market Share by Application (2012-2017)
Table Europe Polypeptide Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Polypeptide Drug by Application (2012-2017)
Figure Germany Polypeptide Drug Sales and Growth Rate (2012-2017)
Figure Germany Polypeptide Drug Revenue and Growth Rate (2012-2017)
Figure Germany Polypeptide Drug Sales Price Trend (2012-2017)
Table Germany Polypeptide Drug Sales by Manufacturers (2015 and 2016)
Table Germany Polypeptide Drug Market Share by Manufacturers (2015 and 2016)
Table Germany Polypeptide Drug Sales by Type (2015 and 2016)
Table Germany Polypeptide Drug Market Share by Type (2015 and 2016)
Table Germany Polypeptide Drug Sales by Application (2015 and 2016)
Table Germany Polypeptide Drug Market Share by Application (2015 and 2016)
Figure France Polypeptide Drug Sales and Growth Rate (2012-2017)
Figure France Polypeptide Drug Revenue and Growth Rate (2012-2017)
Figure France Polypeptide Drug Sales Price Trend (2012-2017)
Table France Polypeptide Drug Sales by Manufacturers (2015 and 2016)
Table France Polypeptide Drug Market Share by Manufacturers (2015 and 2016)
Table France Polypeptide Drug Sales by Type (2015 and 2016)
Table France Polypeptide Drug Market Share by Type (2015 and 2016)
Table France Polypeptide Drug Sales by Application (2015 and 2016)
Table France Polypeptide Drug Market Share by Application (2015 and 2016)
Figure UK Polypeptide Drug Sales and Growth Rate (2012-2017)
Figure UK Polypeptide Drug Revenue and Growth Rate (2012-2017)
Figure UK Polypeptide Drug Sales Price Trend (2012-2017)
Table UK Polypeptide Drug Sales by Manufacturers (2015 and 2016)
Table UK Polypeptide Drug Market Share by Manufacturers (2015 and 2016)
Table UK Polypeptide Drug Sales by Type (2015 and 2016)
Table UK Polypeptide Drug Market Share by Type (2015 and 2016)
Table UK Polypeptide Drug Sales by Application (2015 and 2016)
Table UK Polypeptide Drug Market Share by Application (2015 and 2016)
Figure Russia Polypeptide Drug Sales and Growth Rate (2012-2017)
Figure Russia Polypeptide Drug Revenue and Growth Rate (2012-2017)
Figure Russia Polypeptide Drug Sales Price Trend (2012-2017)
Table Russia Polypeptide Drug Sales by Manufacturers (2015 and 2016)
Table Russia Polypeptide Drug Market Share by Manufacturers (2015 and 2016)
Table Russia Polypeptide Drug Sales by Type (2015 and 2016)
Table Russia Polypeptide Drug Market Share by Type (2015 and 2016)
Table Russia Polypeptide Drug Sales by Application (2015 and 2016)
Table Russia Polypeptide Drug Market Share by Application (2015 and 2016)
Figure Italy Polypeptide Drug Sales and Growth Rate (2012-2017)
Figure Italy Polypeptide Drug Revenue and Growth Rate (2012-2017)
Figure Italy Polypeptide Drug Sales Price Trend (2012-2017)
Table Italy Polypeptide Drug Sales by Manufacturers (2015 and 2016)
Table Italy Polypeptide Drug Market Share by Manufacturers (2015 and 2016)
Table Italy Polypeptide Drug Sales by Type (2015 and 2016)
Table Italy Polypeptide Drug Market Share by Type (2015 and 2016)
Table Italy Polypeptide Drug Sales by Application (2015 and 2016)
Table Italy Polypeptide Drug Market Share by Application (2015 and 2016)
Figure Spain Polypeptide Drug Sales and Growth Rate (2012-2017)
Figure Spain Polypeptide Drug Revenue and Growth Rate (2012-2017)
Figure Spain Polypeptide Drug Sales Price Trend (2012-2017)
Table Spain Polypeptide Drug Sales by Manufacturers (2015 and 2016)
Table Spain Polypeptide Drug Market Share by Manufacturers (2015 and 2016)
Table Spain Polypeptide Drug Sales by Type (2015 and 2016)
Table Spain Polypeptide Drug Market Share by Type (2015 and 2016)
Table Spain Polypeptide Drug Sales by Application (2015 and 2016)
Table Spain Polypeptide Drug Market Share by Application (2015 and 2016)
Figure Benelux Polypeptide Drug Sales and Growth Rate (2012-2017)
Figure Benelux Polypeptide Drug Revenue and Growth Rate (2012-2017)
Figure Benelux Polypeptide Drug Sales Price Trend (2012-2017)
Table Benelux Polypeptide Drug Sales by Manufacturers (2015 and 2016)
Table Benelux Polypeptide Drug Market Share by Manufacturers (2015 and 2016)
Table Benelux Polypeptide Drug Sales by Type (2015 and 2016)
Table Benelux Polypeptide Drug Market Share by Type (2015 and 2016)
Table Benelux Polypeptide Drug Sales by Application (2015 and 2016)
Table Benelux Polypeptide Drug Market Share by Application (2015 and 2016)
Table Novartis Basic Information List
Table Novartis Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Polypeptide Drug Sales Market Share (2012-2017)
Table Merck Serono Basic Information List
Table Merck Serono Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Serono Polypeptide Drug Sales Market Share (2012-2017)
Table Ferring Pharmaceuticals Basic Information List
Table Ferring Pharmaceuticals Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Ferring Pharmaceuticals Polypeptide Drug Sales Market Share (2012-2017)
Table Ipsen PHarma Biotech Basic Information List
Table Ipsen PHarma Biotech Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Ipsen PHarma Biotech Polypeptide Drug Sales Market Share (2012-2017)
Table Lilly Basic Information List
Table Lilly Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Lilly Polypeptide Drug Sales Market Share (2012-2017)
Table Asahi Kasei Basic Information List
Table Asahi Kasei Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Asahi Kasei Polypeptide Drug Sales Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca Polypeptide Drug Sales Market Share (2012-2017)
Table SciClone Pharmaceuticals Basic Information List
Table SciClone Pharmaceuticals Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table SciClone Pharmaceuticals Polypeptide Drug Sales Market Share (2012-2017)
Table Takeda Basic Information List
Table Takeda Polypeptide Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Takeda Polypeptide Drug Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Polypeptide Drug
Figure Manufacturing Process Analysis of Polypeptide Drug
Figure Polypeptide Drug Industrial Chain Analysis
Table Raw Materials Sources of Polypeptide Drug Major Manufacturers in 2016
Table Major Buyers of Polypeptide Drug
Table Distributors/Traders List
Figure Germany Polypeptide Drug Sales and Growth Rate Forecast (2017-2022)
Figure Germany Polypeptide Drug Revenue and Growth Rate Forecast (2017-2022)
Figure France Polypeptide Drug Sales and Growth Rate Forecast (2017-2022)
Figure France Polypeptide Drug Revenue and Growth Rate Forecast (2017-2022)
Figure UK Polypeptide Drug Sales and Growth Rate Forecast (2017-2022)
Figure UK Polypeptide Drug Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Polypeptide Drug Sales and Growth Rate Forecast (2017-2022)
Figure Russia Polypeptide Drug Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Polypeptide Drug Sales and Growth Rate Forecast (2017-2022)
Figure Italy Polypeptide Drug Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Polypeptide Drug Sales and Growth Rate Forecast (2017-2022)
Figure Spain Polypeptide Drug Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Polypeptide Drug Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Polypeptide Drug Revenue and Growth Rate Forecast (2017-2022)
Table Europe Polypeptide Drug Sales Forecast by Type (2017-2022)
Table Europe Polypeptide Drug Sales Forecast by Application (2017-2022)